中國抗體SM17治療特應性皮炎(AD)之臨床前結果刊登於國際科學期刊《Allergy》 SinoMab BioScience Limited Apr 16, 2024 17:44 HKT/SGT Read More
SinoMab BioScience preclinical results of SM17 on atopic dermatitis (AD) published on International Scientific Journal Allergy SinoMab BioScience Limited Apr 16, 2024 17:35 HKT/SGT Read More
Chiron AS in Trondheim, Norway, Has Developed The World's First Commercial Microplastic Reference Materials ZeptoMetrix Apr 09, 2024 22:30 HKT/SGT Read More
French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics Eisai Apr 03, 2024 15:24 HKT/SGT Read More
Eisai Completes Submission of LEQEMBI (lecanemab-irmb) Supplemental Biologics License Application for IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease to the U.S. FDA Eisai Apr 01, 2024 08:39 HKT/SGT Read More
Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical Eisai Mar 29, 2024 14:51 HKT/SGT Read More
Eisai's Brain Health Self-Check Tool "NouKNOW" is Certified as "ME-BYO BRAND" by Kanagawa Prefecture Eisai Mar 29, 2024 14:19 HKT/SGT Read More
Eisai: Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024 Eisai Mar 29, 2024 13:32 HKT/SGT Read More
Sino Biopharm (1177.HK) Announces 2023 Annual Results Sino Biopharmaceutical Limited Mar 29, 2024 11:45 HKT/SGT Read More
Avance Clinical은 세계 백신 대회에서 최신 백신 임상시험 뉴스를 공유합니다. 이 중에는 HIV-1 연구도 포함됩니다 Avance Clinical Mar 29, 2024 06:42 HKT/SGT Read More
Avance Clinical at World Vaccine Congress to Share Latest Vaccine Clinical Trial News Including an HIV-1 Study Avance Clinical Mar 28, 2024 14:42 HKT/SGT Read More
AIM submitted pre-application for human diploid rabies vaccine AIM Vaccine Co., Ltd. Mar 27, 2024 12:20 HKT/SGT Read More
Moderna Achieves Positive Interim Results from Phase 3 Trial of Next-Generation COVID-19 Vaccine Moderna, Inc Mar 26, 2024 19:00 HKT/SGT Read More